Share our success stories and industry insights
浙江越溪胶丸有限公司将参加2026年6月16日至18日在上海新国际博览中心举办的CPHI China 2026，展位号E6D51，诚邀全球客户莅临洽谈空心胶囊、明胶胶囊及HPMC植物胶囊合作。
浙江越溪胶丸有限公司将参加2026年6月16日至18日在上海新国际博览中心举办的CPHI China 2026，展位号E6D51，诚邀全球客户莅临洽谈空心胶囊、明胶胶囊及HPMC植物胶囊合作。
GLP-1 oral drugs drive unprecedented demand for capsule manufacturing. Amgen, Eli Lilly, and Novo Nordisk race for $100B market. AI and nearshoring reshape pharma manufacturing.
Empty capsules market hits $3.5B in 2026. HPMC capsules lead at 10%+ CAGR, Asia-Pacific manufacturing rises, AI transforms production quality.
April 2026 Pharmaceutical Industry Update: Supply Chain Resilience, GLP-1 Innovation, and AI in Manufacturing 1. Supply Chain Crisis: Strait of Hormuz Disruption A geopolitical escalation has disrupte
Strategic Alliance for Mutual Growth: YOKO BIOPHARM and Zhejiang Yuexi Capsule Co., Ltd. Sign Long-term Cooperation Agreement
80+ R&D Team in Support, High-Efficiency Equipment & Full-Range Capsules Light Up 110+ Overseas Markets
Vegetable Capsules Become New Industry Trend: YOKO BIOPHARM Leads Global Market with Full-Chain Layout
Policy and Technology Dual Drive: The Empty Capsule Industry Steps into a New Stage of High-quality Development
